CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in TYRA — Tyra Biosciences, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in TYRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,550,306
+$924,355 QoQ
Shares Held
267,699
+34.4% QoQ
Ownership
0.449%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 169 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TYRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. TYRA ranks #109 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in TYRA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,550,306 | 267,699 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,625,951 | 199,111 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,242,909 | 199,426 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,820,202 | 201,587 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,704,455 | 178,104 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $2,371,340 | 170,600 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,084,556 | 173,737 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,717,420 | 169,945 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,496,276 | 152,212 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,530,937 | 110,537 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,517,646 | 110,214 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,782,308 | 104,657 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,645,085 | 102,370 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $748,622 | 98,503 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $845,378 | 96,175 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $581,302 | 81,301 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $860,879 | 80,456 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,116,412 | 79,347 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||